# PALIPERIDONE
> **ANDA218330** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2024-09-26
## Drug
- **FDA Application Number:** ANDA218330
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALIPERIDONE
- **Generic name:** PALIPERIDONE
- **Active ingredients:** PALIPERIDONE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Limited
- **First approval:** 2024-09-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218330)
---
*MORVS · CC0 1.0*